Atlas Trials

PF-06671008 Dose Escalation Study in Advanced Solid Tumors

Clinical trial NCT02659631 · TERMINATED

Trial details

NCT number
NCT02659631
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2016-04-28
Primary completion
2019-03-29
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.